(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Robert Lee Hotz

Here is what's making health news:

FDA Warns About Fakes of ADHD Drug Adderall (WSJ): A counterfeit version of Teva Pharmaceutical Industries Ltd.'s TEVA 0.00% Adderall, is being sold on websites, the Food and Drug Administration warned Tuesday. The fake pills could pose a health risk, but so far there are no reports of harm, an agency spokeswoman said.

Vertex Says Efficacy of Drug Was Overstated (WSJ): Vertex Pharmaceuticals Inc. VRTX -10.87% said Tuesday it overstated the efficacy of a cystic-fibrosis therapy earlier this month when the company released data that bolstered investor hopes the therapy would have blockbuster sales potential.

Working the Night Shift May Boost Breast Cancer Risk (Time Healthland Blog): Researchers in Denmark reported in the journal Occupational and Environmental Medicine that women who worked night shifts were up to four times more likely to develop breast cancer than women who didn't work nights.

Aspirin and other NSAIDs may protect against skin cancer (LA Times):

Scientists analyzed 19 years of skin cancer records and reported in the journal Cancer that aspirin and other nonsteroidal anti-inflammatory painkillers may help protect against skin cancer. They compared the rates of skin cancer in those who took one or more of these drugs with those who didn't.

Psychiatric Manual May Soon Include 'Gambling Disorder' (NPR): Proposed revisions to the Diagnostic and Statistical Manual of Mental Disorders would add "gambling disorder" to alcohol and drug problems as a "substance use and addictive disorder" that insurers and others would use to make decisions about treatment and coverage.

 
 -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com. 
 
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024 Plus de graphiques de la Bourse Teva Pharmaceutical Indu...
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024 Plus de graphiques de la Bourse Teva Pharmaceutical Indu...